Literature DB >> 11698807

A Two-stage bipodal screening model for universal neonatal hearing screening.

P J Govaerts1, M Yperman, G De Ceulaer, K Daemers, K Van Driessche, T Somers, F E Offeciers.   

Abstract

OBJECTIVE: A model is proposed for universal neonatal hearing screening.
METHODS: The screening model is two-staged because it consists of a first test and, in case of failure (1.4% of the subjects), of a retest 3 weeks later. It is bipodal because it involves both the hospital audiologic department and a central Well Baby Organization. The idea is to have a maximal number of newborns tested at the maternity by trained audiologists and to have the Well Baby Organization trace and chase the missing subjects. The model has been evaluated during 1 calendar year (1999) in a maternity with 2,012 newborns. RESULT: The result is a coverage of 99.3%. Most newborns (97.3%) were tested at the maternity ward with a total time investment of less than 15 minutes per child. The actual test time is 2 minutes, 12 seconds (median value). The Well Baby Organization keeps track of all the results and has to test no more than 2% of the newborns. Sensitivity and specificity were not the primary outcomes of this evaluation, but they were similar to those of a previous study evaluating the screen procedure on a larger scale, giving a sensitivity of approximately 100% and a false alarm rate of 1/1,000.
CONCLUSION: These figures demonstrate that universal neonatal hearing screening is feasible within the existing health care structure, with unprecedented coverage, sensitivity, and specificity.

Entities:  

Mesh:

Year:  2001        PMID: 11698807     DOI: 10.1097/00129492-200111000-00023

Source DB:  PubMed          Journal:  Otol Neurotol        ISSN: 1531-7129            Impact factor:   2.311


  6 in total

Review 1.  Universal neonatal hearing screening moving from evidence to practice.

Authors:  C Kennedy; D McCann
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2004-09       Impact factor: 5.747

2.  Interdisciplinary approach to design, performance, and quality management in a multicenter newborn hearing screening project. Discussion of the results of newborn hearing screening in Hamburg (part II).

Authors:  Anna-Katharina Rohlfs; Thomas Wiesner; Holger Drews; Frank Müller; Achim Breitfuss; Regina Schiller; Markus Hess
Journal:  Eur J Pediatr       Date:  2010-06-11       Impact factor: 3.183

3.  Clinical features of patients with GJB2 (connexin 26) mutations: severity of hearing loss is correlated with genotypes and protein expression patterns.

Authors:  Tomohiro Oguchi; Akihiro Ohtsuka; Shigenari Hashimoto; Aki Oshima; Satoko Abe; Yumiko Kobayashi; Kyoko Nagai; Tatsuo Matsunaga; Satoshi Iwasaki; Takashi Nakagawa; Shin-Ichi Usami
Journal:  J Hum Genet       Date:  2005-02-08       Impact factor: 3.172

4.  A genotype-phenotype correlation for GJB2 (connexin 26) deafness.

Authors:  K Cryns; E Orzan; A Murgia; P L M Huygen; F Moreno; I del Castillo; G Parker Chamberlin; H Azaiez; S Prasad; R A Cucci; E Leonardi; R L Snoeckx; P J Govaerts; P H Van de Heyning; C M Van de Heyning; R J H Smith; G Van Camp
Journal:  J Med Genet       Date:  2004-03       Impact factor: 6.318

5.  Universal neonatal audiological screening: experience of the University Hospital of Pisa.

Authors:  Paolo Ghirri; Annalisa Liumbruno; Sara Lunardi; Francesca Forli; Antonio Boldrini; Angelo Baggiani; Stefano Berrettini
Journal:  Ital J Pediatr       Date:  2011-04-11       Impact factor: 2.638

6.  Protocol and programme factors associated with referral and loss to follow-up from newborn hearing screening: a systematic review.

Authors:  Allison R Mackey; Andrea M L Bussé; Valeria Del Vecchio; Elina Mäki-Torkko; Inger M Uhlén
Journal:  BMC Pediatr       Date:  2022-08-05       Impact factor: 2.567

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.